biospace.com
域名年龄: 30年4个月7天HTTP/1.1 200 OK 缓存控制:private 类型:text/html; charset=utf-8 访问时间:2016年02月22日 14:41:00 文件大小:75033 网站编码:utf-8
Employer:LoginPost JobsJob Seeker:LoginSign UpHomeNewsJobsCareer ResourcesHotbedsCareer EventsEventsCompany ProfilesInvestorsSearch Life Sciences JobsSearch Job Title OnlyRadius:MilesKm80.5Breaking NewsGoogle's Verily to Lease Onyx's Old Space in South San Francisco, Campus Can House Up To 1,000February 18, 2016: Verily Life Sciences, made a big move by securing the 400,000 square-foot space formerly occupied by Onyx in the heart of San Francisco’s biotech industry, the San Francisco Business Times reported this afternoon.Breaking NewsOnconova Cuts 17% of Staff and CEO Takes $136K Pay CutFebruary 18, 2016: Onconova, in an effort to cut costs and hold on to its cash, indicated it is cutting 17 percent of its workforce, including the company’s CFO and president of R&D. The company’s CEO, Ramesh Kumar, has also agreed to cut his base salary by $136,000 this year.Breaking NewsHemispherx Fires CEO After Months of Re-Examining Priorities, Writes Out a Strict Anti-Nepotism PolicyFebruary 19, 2016: Hemispherx stock jumped about 13 cents per share, a five percent increase, following the termination of William Carter, the company’s chairman and CEO, Wallstreet.org reported this morning.Breaking NewsCambridge Biotech AVROBIO Launches with Former MassBio Chair as CEOFebruary 19, 2016: Atlas Venture, launched another Cambridge biotech startup yesterday, AvroBio. No financial details were disclosed. The company is founded on two novel cell and gene therapies.‹›Search the Site:NewsCompaniesEventsUse only alphanumeric charactersTop Breaking NewsAround the WebPopular NewsGoogle (GOOG)'s Verily to Lease Onyx (AMGN)'s Old Space in South San Francisco, Campus Can House Up to 1,000Onconova (ONTX) Cuts 17% of Staff and CEO Takes $136K Pay CutHemispherx (HEB) Fires CEO Following Reexamination of Priorities, Implements Ant-Nepotism PolicyCambridge Biotech AVROBIO Launches with Former MassBio Chair as CEONovartis AG (NVS)'s Leukemia Drug Gets Breakthrough Designation, Same Week as AstraZeneca PLC (AZN) and Roche (RHHBY) DrugsNeothetics (NEOT) Stock Plunges Following Abrupt CEO ResignationBayer (BAY) Strategy Head Expected to be Named CEO Next WeekSpin-Offs to Stay in Del. After DuPont (DD), Dow Chemical (DOW) Merger, New Structure OutlinedCharts Show Biogen (BIIB) and Other Biotech Stocks are About to RallyProsecutors Claim Potential Witnesses Fear Retaliation from Martin ShkreliPliant Launches in the Bay Area With $45 Million and Former Johnson & Johnson (JNJ) and Celgene (CELG) Execs At the Wheel303 Fetal Deaths May be Linked to Bayer HealthCare (BAY)'s Essure; Congressman Raises New Concerns About Contraceptive DeviceGilead (GILD)’s New CEO, John Milligan, Hints at Probable Mergers and AcquisitionsRoche (RHHBY)'s Multiple Sclerosis Drug Gets Breakthrough Status, Likely to Haunt Biogen (BIIB)Adaptive Biotech, Juno (JUNO), NanoString (NSTG) Continue Hiring Spree in SeattleZafgen (ZFGN) Surges as Obesity Drug Succeeds in Phase IIb TrialCorvidia Therapeuti
© 2010 - 2020 网站综合信息查询 同IP网站查询 相关类似网站查询 网站备案查询网站地图 最新查询 最近更新 优秀网站 热门网站 全部网站 同IP查询 备案查询
2025-05-30 07:41, Process in 0.0063 second.